Announcements Trials
Browse Landscape

Phase

Phase 1 5

Status

Unknown 2Completed 2Terminated 1

Sponsor Class

INDUSTRY 5

Study Type

Interventional 5

Sponsor

Cancer Type

Other solid neoplasm 5

Conditions

Advanced Solid Tumors 2Unspecified Adult Solid Tumor, Protocol Specific 1Solid Tumors 1Solid Tumor 1

Interventions

Cisplatin 70Paclitaxel 68pembrolizumab 65Carboplatin 61Irinotecan 59Injections 53Gemcitabine 53Docetaxel 49Fluorouracil 35Cyclophosphamide 35Pemetrexed 34Oxaliplatin 31Capecitabine 30Bevacizumab 29Leucovorin 27atezolizumab 23Nivolumab 23tislelizumab 19Etoposide 18Cetuximab 17durvalumab 16Temozolomide 16Bortezomib 16alvocidib 15Topotecan 15olaparib 14Sorafenib 14Rifampin 14Itraconazole 14Erlotinib Hydrochloride 14

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Phase 1 × tesetaxel × Other solid neoplasm × Clear all
NCT04312282 2021-07-28

The Effect of Tesetaxel on the QTc Interval and the Effect of Food, Itraconazole, and Rifampin on Tesetaxel Pharmacokinetics in Patients With Advanced Solid Tumors

Odonate Therapeutics, Inc.

Phase 1 Terminated
93 enrolled
Other solid neoplasm

Advanced Solid Tumors

NCT01170975 2012-07-24

Effects of Food on the Pharmacokinetics of Tesetaxel 10 mg Capsules

Genta Incorporated

Phase 1 Completed
12 enrolled
Other solid neoplasm

Solid Tumors

NCT01315431 2012-07-24

A Study of Tesetaxel Plus Capecitabine in Patients With Solid Tumors

Genta Incorporated

Phase 1 Unknown
9 enrolled
Other solid neoplasm

Solid Tumor

NCT00077077 2012-05-16

DJ-927 and Capecitabine in Treating Patients With Locally Advanced or Metastatic Solid Tumors

Daiichi Sankyo

Phase 1 Completed
Other solid neoplasm

Unspecified Adult Solid Tumor, Protocol Specific

NCT01337310 2012-03-13

Study of Tesetaxel in Japanese Patients With Solid Tumors

Genta Incorporated

Phase 1 Unknown
12 enrolled
Other solid neoplasm

Advanced Solid Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡